EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intestinal Gastrin/CCKBR Axis Protects against Type 2 Diabetes by Reducing Intestinal Glucose Absorption through the PI3K/Akt/eIF4B Signaling Pathway

Xue Liu, Xing Liu, Yunpeng Liu, Anxiong Long, Wei Liu, Shiyun Sun, Shuaibing Lu, Xianxian Wu, Xiaodi Jia, Pedro A Jose, Qiang Wei, Xiaoliang Jiang und 2 weitere

Advanced Science · 2025

DOI: 10.1002/advs.202410032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Xue Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Laboratory Animal Sciences (CAMS & PUMC), National Center of Technology Innovation for Animal Model, National Human Diseases Animal Mode…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Gastrins, Glucose, Intestinal Absorption. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Key Research and Development Program, National Natural Science Foundation (China).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Gastrin/CCKBR axis is essential for inhibiting intestinal sodium absorption, but its effects on intestinal glucose metabolism remain elusive. This study aims to determine the role of intestinal Gastrin/CCKBR on glucose absorption in the development of type 2 diabetes (T2D). Intestinal epithelial cell‐specific Cckbr knockout mice and control wild‐type mice are fed normal diet (ND, 10% fat) or high fat diet (HFD, 60% fat) to study the effect of intestinal Gastrin/CCKBR on blood glucose levels. Gastrin‐SiO 2 microspheres (20 mg kg −1 d −1 ) are designed so that gastrin specifically stimulates intestinal CCKBR, without its absorption into the circulation. Mice with silenced intestinal Cckbr has pre‐diabetes mellitus (Pre‐DM) that rapidly progressed into T2D when fed HFD. Moreover, Gastrin‐SiO 2 microspheres markedly reduce glucose absorption in duodenum obtained from patients with T2D. In mice with HFD‐induced T2D, Gastrin‐SiO 2 microspheres reduce intestinal glucose absorption by down‐regulating intestinal SGLT1 and GLUT2 expressions and stimulating incretin secretion. This study shows the important role of intestinal Gastrin/CCKBR in intestinal glucose absorption. Gastrin‐SiO 2 microspheres may be a promising strategy for the treatment of patients with T2D.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2GastrinsGlucoseIntestinal AbsorptionReceptor, Cholecystokinin BAnimalsMiceSignal TransductionMaleMice, KnockoutHumansProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesDiet, High-FatMice, Inbred C57BL

Stichwörter der Autor:innen

Gastrin‐SiO2 microspherescholecystokinin B receptorglucose transporter type 2sodium/glucose cotransporter 1type 2 diabetes

Substanzen

GastrinsGlucoseReceptor, Cholecystokinin BProto-Oncogene Proteins c-aktPhosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • Institute of Laboratory Animal Sciences (CAMS & PUMC), National Center of Technology Innovation for Animal Model, National Human Diseases Animal Model Resource Center, NHC Key Laboratory of Human Disease Comparative Med…
  • Department of Cardiology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, State Key Laboratory of Transvascular Implantation Devices, Heart Regeneration and Repair Key Laboratory Zhejiang Provin…
  • Graduate School of Hebei North University, Zhangjiakou, Hebei, 075031, China.
  • Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100021, Beijing, China.
  • State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, Chi…
  • Taihe County People's Hospital, The Taihe Hospital of Wannan Medical College, 21 Jiankang Road, Taihe County, Anhui Province, 236600, China.

ORCID-Profile: Zhiwei Yang

Förderung

  • NIDDK NIH HHS
  • National Key Research and Development Program
  • National Natural Science Foundation (China)
  • Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
  • NIH HHS
  • NHLBI NIH HHS
  • National Key Research and Development Program of China
  • National Institutes of Health

Zitieren

APA

Liu, X., Liu, X., Liu, Y., Long, A., Liu, W., Sun, S., Lu, S., Wu, X., Jia, X., Jose, P. A., Wei, Q., Jiang, X., Zhang, H., & Yang, Z. (2025). Intestinal Gastrin/CCKBR Axis Protects against Type 2 Diabetes by Reducing Intestinal Glucose Absorption through the PI3K/Akt/eIF4B Signaling Pathway. Advanced Science. https://doi.org/10.1002/advs.202410032

Vancouver

Liu X, Liu X, Liu Y, Long A, Liu W, Sun S, et al. Intestinal Gastrin/CCKBR Axis Protects against Type 2 Diabetes by Reducing Intestinal Glucose Absorption through the PI3K/Akt/eIF4B Signaling Pathway. Advanced Science. 2025. doi:10.1002/advs.202410032

BibTeX
@article{Liu2025,
  author = {Liu, Xue and Liu, Xing and Liu, Yunpeng and Long, Anxiong and Liu, Wei and Sun, Shiyun and Lu, Shuaibing and Wu, Xianxian and Jia, Xiaodi and Jose, Pedro A and Wei, Qiang and Jiang, Xiaoliang and Zhang, Haizeng and Yang, Zhiwei},
  title = {Intestinal Gastrin/CCKBR Axis Protects against Type 2 Diabetes by Reducing Intestinal Glucose Absorption through the PI3K/Akt/eIF4B Signaling Pathway},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202410032}
}
Kostenlos starten →